Capsaicin-Astaxanthin Composition for Inflammatory Skin Aging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current anti-aging nutritional products do not effectively address the inflammatory component of skin diseases, leading to accelerated skin aging and the condition known as inflammaging, which is characterized by chronic inflammation and oxidative stress.

Innovation Solution

A combination composition of capsaicin or phenylcapsaicin and astaxanthin, which synergistically activates the Nrf2 transcription factor system, down-regulates NF-kβ activation, and reduces pro-inflammatory cytokine expression, thereby reducing oxidative stress and inflammatory processes, promoting cellular defense and delaying skin aging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current anti-aging nutritional products are used, then general nutritional support is provided, but they do not effectively address the inflammatory component of skin diseases

Engineering Contradiction:
Improveeffectiveness in treating inflammatory skin diseasesVSAvoidspecific activity against inflammaging
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines capsaicin or phenylcapsaicin with astaxanthin in a single composition to achieve synergistic anti-inflammatory and antioxidant effects. This merging of two distinct bioactive compounds addresses the limitation of single-component products by providing both NF-κB inhibition (from capsaicin/phenylcapsaicin) and oxidative stress protection (from astaxanthin), thereby effectively treating inflammatory skin diseases while maintaining versatility.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite nutritional product integrating two different bioactive substances with complementary mechanisms of action. Capsaicin/phenylcapsaicin provides anti-inflammatory effects through NF-κB pathway modulation, while astaxanthin contributes antioxidant and anti-inflammatory properties, forming a composite material that specifically targets inflammaging with enhanced reliability compared to single-component products.

Inventive Principle:
Principle #40Composite materials

2Reliability

If persistent inflammatory state is allowed to continue, then chronic skin diseases develop, but this leads to accelerated skin aging and inflammaging

Engineering Contradiction:
Improveprevention of chronic skin diseasesVSAvoidduration of inflammatory state
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The composition acts preliminarily to prevent the development of chronic inflammatory skin diseases by continuously suppressing NF-κB activation and reducing oxidative stress. By maintaining constant anti-inflammatory and antioxidant activity through the synergistic combination of capsaicin/phenylcapsaicin and astaxanthin, the product prevents the transition from acute to chronic inflammation, thereby preventing skin aging before it occurs.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent ensures continuous protection against inflammatory processes and oxidative stress through the sustained activity of the capsaicin/phenylcapsaicin-astaxanthin combination. This continuous action prevents intermittent inflammatory episodes from accumulating and progressing to chronic conditions, thereby extending skin health and preventing inflammaging over time.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If exposure to external agents continues, then skin barrier function weakens, but this promotes inflammatory conditions and accelerates aging

Engineering Contradiction:
Improveskin barrier functionVSAvoidimpact of external agents
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The composition provides beforehand cushioning by pre-establishing enhanced cellular defense mechanisms through the synergistic action of capsaicin/phenylcapsaicin and astaxanthin. This preparatory protection strengthens the skin's resistance to external agents before damage occurs, cushioning against UV radiation, pollution, and other environmental stressors that would otherwise weaken the barrier function and trigger inflammation.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Solution Approach 2:

The invention converts the harmful effects of external agents into beneficial adaptive responses by inducing controlled activation of cellular defense pathways. The capsaicin/phenylcapsaicin-astaxanthin combination triggers beneficial stress responses that enhance skin resilience, transforming the potential harm from environmental exposure into strengthened barrier function and improved anti-inflammatory capacity.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination composition effectively reduces skin inflammation, slows down skin aging, and improves skin health by enhancing cellular defenses and reducing degenerative processes, making it suitable for treating skin diseases with inflammatory components and signs of premature aging.

Implementation Method 1

synergistically activates the Nrf2 transcription factor system

Methodology Applied
Scientific EffectTranscription factor activation:

Implementation Method 2

activate the Nrf2/ARE pathway and the expression of protective genes

Methodology Applied
Scientific EffectGene expression regulation:

Implementation Method 3

down-regulates NF-kβ activation and the expression of pro-inflammatory cytokines

Methodology Applied
Scientific EffectSignal pathway inhibition:

Implementation Method 4

reducing oxidative stress and inflammatory processes

Methodology Applied
Scientific EffectAntioxidant activity: Oxidation

Data Source

PatentEP4279068A1Composition comprising a combination of capsaicin and/or phenylcapsaicin and astaxanthin for the prevention and treatment of inflammatory-based skin diseases, in particular associated with skin aging
Publication Date: 2023.11.22 SAFI MEDICAL CARE SRL
  • EP4279068A1 patent drawingFigure 1a~1e
  • EP4279068A1 patent drawingFigure 2
  • EP4279068A1 patent drawingFigure 3a~3d

AI summary

The present invention concerns a composition containing capsaicin or phenylcapsaicin in combination with astaxanthin which are dispersed in a physiologically acceptable vehicle and a food supplement containing the composition. The supplement finds application in the prevention and treatment of inflammatory-based skin diseases in particular associated with skin aging such as inflammaging.